BIOLASE, Inc. (BIOL)’in fiyatı nedir?

BIOLASE, Inc. (BIOL)’in fiyatı $0.00695’dir

BIOLASE, Inc. (BIOL)’in piyasa değeri nedir?

BIOLASE, Inc. (BIOL)’in piyasa değeri $536.40’dir.

BIOLASE, Inc. (BIOL) F/DD Oranı

BIOLASE, Inc., along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally. The sophisticated laser instruments developed by BIOLASE empower a diverse array of dental specialists—including general dentists, periodontists, endodontists, and oral surgeons—to execute a broad spectrum of minimally invasive procedures. These applications range from cosmetic enhancements and restorative treatments to intricate surgical interventions. Among its core product offerings, the company provides Waterlase all-tissue dental laser systems, which are highly effective for precisely cutting both soft and hard tissues. It also supplies diode soft-tissue laser systems, utilized for procedures involving soft tissue, pain management, teeth whitening, and various other aesthetic treatments. Furthermore, the Epic Hygiene laser assists in addressing non-surgical periodontitis and enhancing overall clinical efficiency. Beyond its primary laser devices, BIOLASE also manufactures and distributes essential consumable items and accessories. This comprehensive range includes flexible fibers, specialized hand pieces, and professional teeth whitening gel kits. The company markets its products through a dedicated in-house sales team and an extensive network of distributors. Established in 1984, the organization was initially known as BIOLASE Technology, Inc., before officially changing its name to BIOLASE, Inc. in 2012. Its corporate headquarters are situated in Foothill Ranch, California.

Yıl	P/B Oranı	Değiştir
2026 (TTM)	-0.10	-98.22%
2023	-5.80	-728.93%
2022	0.92	-59.69%
2021	2.29	-10.73%
2020	2.56	-92.44%
2019	33.85	1,741.55%
2018	1.84	69.59%
2017	1.08	-71.84%
2016	3.85	96.28%
2015	1.96	-30.30%
2014	2.81	-75.72%
2013	11.59	120.47%
2012	5.26	-17.68%
2011	6.38	-142.09%
2010	-15.17	-342.77%
2009	6.25	52.49%
2008	4.10	12.38%
2007	3.65	-63.50%
2006	9.99	8.10%
2005	9.24	16.63%
2004	7.92	-32.36%
2003	11.71	-48.01%
2002	22.53	-70.00%
2001	75.09	129.62%
2000	32.70	0.00%

Yıl

P/B Oranı

Değiştir

2026 (TTM)

-0.10

-98.22%

2023

-5.80

-728.93%

2022

0.92

-59.69%

2021

2.29

-10.73%

2020

2.56

-92.44%

2019

33.85

1,741.55%

2018

1.84

69.59%

2017

1.08

-71.84%

2016

3.85

96.28%

2015

1.96

-30.30%

2014

2.81

-75.72%

2013

11.59

120.47%

2012

5.26

-17.68%

2011

6.38

-142.09%

2010

-15.17

-342.77%

2009

6.25

52.49%

2008

4.10

12.38%

2007

3.65

-63.50%

2006

9.99

8.10%

2005

9.24

16.63%

2004

7.92

-32.36%

2003

11.71

-48.01%

2002

22.53

-70.00%

2001

75.09

129.62%

2000

32.70

0.00%

Şirket	P/B Oranı	P/B Oranı Farkı	Ülke
Abbott Laboratories ABT.US	3.6048	-3,582.90%	US
Stryker Corporation SYK.US	5.207	-5,130.92%	US
Medtronic plc MDT.US	2.0146	-2,046.47%	IE
Boston Scientific Corporation BSX.US	2.6697	-2,679.42%	US
Edwards Lifesciences Corporation EW.US	4.8038	-4,741.35%	US

Şirket

P/B Oranı

P/B Oranı Farkı

Ülke